Taiwan FDA registration 30a6b9ff6bac7cfd599b46a86816bbed

Abbott "Marisi" Human immunodeficiency virus antigen and antibody test reagent

TW: 亞培"妙芮絲" 人類免疫缺乏病毒抗原及抗體檢驗試劑
Taiwan flagTaiwan·Risk Class 3·DIASORIN S.P.A. UK BRANCH·Registered Jul 02, 2004 – Jul 02, 2024Expired
Registration details
Analysis ID
30a6b9ff6bac7cfd599b46a86816bbed
Customs Code
DHA00601074006
Company information
Manufacturer Country
United Kingdom
Product details
Intended Use
Enzyme immunoassay for enhancing human immunodeficiency virus type 1 (HIV-1. HIV-1 O) and type 2 (HIV-2) detection.
Product Type (Level 1)
B Hematology, pathology, and genetics
Import Information
import
Dates and status
Registration Date
Jul 02, 2004
Expiry Date
Jul 02, 2024
About this record

Access comprehensive regulatory information for Abbott "Marisi" Human immunodeficiency virus antigen and antibody test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 30a6b9ff6bac7cfd599b46a86816bbed and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices